MOST RECENT
The Gates Foundation, Novo Nordisk Foundation and Open Philanthropy are collaborating under a partnership called Pandemic Antiviral Discovery, funding research to develop treatments that may be needed for future pandemics.
In this candid conversation, the storied investor and mega-donor discusses what he and his wife Fiona look for in grantees, how much they plan to give away, why they won’t sign the Giving Pledge, and more.
Stanley and Fiona Druckenmiller have a $1.9 billion foundation and a reported fortune of $10 billion. Here’s a closer look at how the couple makes big bets for economic mobility, the environment and health.
With a $100 million commitment, the Howard Hughes Medical Institute is the latest funder backing research to prepare for pathogens with the potential to threaten human health, or even trigger new pandemics.
Paul and Diane Manning, longtime supporters of diabetes research at the University of Virginia, recently committed $100 million to build an advanced biotech research institute there. Here’s a rundown on the gift and the donors.
Sergey Brin’s foundation has nearly $5 billion in assets and a portfolio spanning Parkinson’s disease, science and activism. It’s not known for transparency, but we do know a fair amount about what it supports and why.
As part of IP’s State of American Philanthropy project, we recently published an in-depth paper on trends in cancer research funding. Author Mike Scutari overviews what we learned and offers clues on what to expect going forward.
The Chicago-based Muscular Dystrophy Association is a leading funder in the field of neuromuscular diseases. We check in with Chief Research Officer Dr. Sharon Hesterlee to discuss current challenges and priorities.
The FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.
Top grantmakers from Asia and the U.S. have joined forces on a new Philanthropy Asia Alliance, and are already backing six on-the-ground projects. The alliance highlights Singapore’s role as a hub for Asian philanthropy.
Since her husband David Koch’s passing in 2019, Julia Koch has kept a fairly low philanthropic profile. But the sheer scale of her fortune means much larger giving may be coming down the line. Here are a few things to look out for.
The Bezos family’s mega-commitment to the Fred Hutchinson Cancer Center will fund cancer and infectious disease research. The gift has a 20-year backstory, and offers a peek at how the fantastically wealthy clan operates.
Once viewed as the “graveyard of neuroscience,” the field of spinal cord injury has made headway thanks to the Christopher & Dana Reeve Foundation. We check in with two leaders to discuss challenges and opportunities.
Philanthropy was more active than usual in last week’s United Nations General Assembly, as the secretary general called for a “rescue mission” to get Sustainable Development Goals on track. Here’s a rundown of the big pledges.
Michael Bloomberg just received his third reappointment as global ambassador for noncommunicable diseases and injuries. The mega-donor shared some insights with IP on how donors can impact global health and more.
The Parkinson's Foundation in the U.S. and Parkinson's U.K. have inked a new partnership to boost investment in treatments for the neurodegenerative condition that affects 10 million people worldwide.
Often missed or misdiagnosed, lupus disproportionately affects women of color in the U.S. Here’s how a leading lupus research funder is speeding along the development of much-needed treatments.
The Africa Frontline First Catalytic Fund is setting its sights on compensating and training community health workers, who play a crucial role in addressing public health problems. Two major foundations have already signed on.
A team of researchers discovered that work on some of the most lethal types of cancer is consistently underfunded. We dig into their findings with co-author Suneel Kamath, MD.
The Open Medicine Foundation supports research into Long COVID, ME/CFS, and other complex, chronic conditions, but research dollars are few and the fallout of these conditions is devastating.
Philanthropic funding has played a major role in a highly successful international effort to combat a disease that was once widespread across the globe. But the fight isn’t over yet.
Bloomberg Philanthropies is putting more major money behind a global effort to combat cardiovascular disease. It remains the top cause of death in low and middle-income countries, but draws in relatively little aid funding.
Bill Gates’ ultra-gift of $20 billion to the Bill & Melinda Gates Foundation reaffirms his place as a titan of modern philanthropy. It also signals more of the same to come from the foundation — for better or worse.
With a new $500 million commitment from its founder, the Mark Foundation for Cancer Research is ramping up its grantmaking and venture investing. It has also gotten behind an international research initiative.
Open Philanthropy and GiveWell are bringing their close-knit effective altruist partnership to bear on the problem of unsafe water. Here’s how they’re helping provide community chlorine dispensers to several African countries.
A new report found that funders dialed back COVID-related support in 2021, although total grantmaking increased over the previous year. Two years into the pandemic, most of this support still takes the form of restricted funding.
The 76-year-old Gates Family Foundation serves the state of Colorado using a leadership structure that blends community governance with family interests. The latest example is a $100 million medical research gift.
A collaboration of Open Society Foundations, the Clinton Health Access Initiative and other global health organizations and companies aims to augment vaccination efforts with the use of COVID antiviral medicines.
Neglected tropical diseases (NTDs) remain a stubborn problem in some parts of the world, but there is momentum to eliminate them. Here’s how a big new commitment from the Helmsley Charitable Trust fits in.
Philanthropy represents only a fraction of global health spending, and large foundations dominate U.S. giving for global health. Still, COVID-19 has led to an uptick, both from established funding leaders and others.